Tuberculosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Confirmed tuberculosis patients (including general tuberculosis and multi-drug resistant tuberculosis); 2.Age 18-75 years; 3.Is currently undergoing anti-tuberculosis medication treatment; 4.Voluntarily sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Patients with severe coagulation dysfunction; 2.Patients with end-stage liver and kidney failure; 3.Individuals with mental illnesses who are unable to cooperate;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consistency between DBS and venous blood anti-tuberculosis drug concentration detection results; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical efficacy indicators for tuberculosis patients (sputum conversion rate, lesion absorption);Incidence rate of adverse events related to DBS sampling;Incidence of adverse reactions related to anti-tuberculosis drug treatment; | — |
Countries
China
Contacts
Hangzhou Red Cross Hospital